FDA opens preliminary inquiry into risks of epilepsy drugs
The FDA has begun an inquiry into whether epilepsy drugs may increase the risk of suicidal behavior in some patients, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.